Envista Corp

17.43
-0.05 (-0.29%)
At close: Mar 25, 2025, 3:59 PM
19.92
14.24%
Pre-market: Mar 26, 2025, 07:38 AM EDT
-0.29%
Bid 17.5
Market Cap 3B
Revenue (ttm) 2.51B
Net Income (ttm) -1.12B
EPS (ttm) -6.5
PE Ratio (ttm) -2.68
Forward PE 19.29
Analyst Hold
Ask 22.5
Volume 1,568,354
Avg. Volume (20D) 2,471,906
Open 17.49
Previous Close 17.48
Day's Range 17.30 - 17.73
52-Week Range 15.14 - 23.00
Beta 1.33

About NVST

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Cons...

Sector Healthcare
IPO Date Sep 18, 2019
Employees 12,300
Stock Exchange NYSE
Ticker Symbol NVST
Full Company Profile

Analyst Forecast

According to 14 analyst ratings, the average rating for NVST stock is "Hold." The 12-month stock price forecast is $21, which is an increase of 20.45% from the latest price.

Stock Forecasts

Next Earnings Release

Envista Corp is scheduled to release its earnings on Apr 30, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+5.93%
Envista Holdings shares are trading higher after t... Unlock content with Pro Subscription
4 months ago
+9.05%
Envista Holdings shares are trading higher after Leerink Partners upgraded the stock from Underperform to Market Perform and raised its price target from $16 to $23. Additionally, Baird raised its price target on the stock from $17 to $22.